Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs112533069 | chr6:15211657 | C/T | 0.000123 | 131 | 37.53 | 45.93 | NA | KM Plot |
| TGCT | rs11255761 | chr10:8628174 | C/A | 3.88E-7 | 133 | 43.68 | 33.53 | 17.58 | KM Plot |
| TGCT | rs112574597 | chr20:57202148 | CTGAGACCA/C | 4.43E-9 | 129 | 37.2 | 60.63 | 9.02 | KM Plot |
| TGCT | rs112588913 | chr13:21844277 | C/T | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs112698361 | chr2:29496827 | T/C | 0 | 134 | 42.27 | 25.02 | 0.57 | KM Plot |
| TGCT | rs112743744 | chr14:78143407 | G/C | 7.4E-5 | 134 | 45.1 | 39.38 | 18.07 | KM Plot |
| TGCT | rs112784543 | chr7:127759893 | G/A | 1.25E-13 | 134 | 45.1 | 36.23 | 17.1 | KM Plot |
| TGCT | rs11306877 | chr8:116914050 | TA/T | 7.41E-7 | 134 | 45.7 | 28.7 | 18.83 | KM Plot |
| TGCT | rs113145976 | chr6:28438650 | T/C | 0 | 132 | 46.53 | 25 | 0.57 | KM Plot |
| TGCT | rs113231411 | chr5:74583218 | T/C | 1.81E-5 | 128 | 45.47 | 28.8 | 9.27 | KM Plot |
| TGCT | rs113267847 | chr5:1816959 | G/A | 5.54E-6 | 134 | 42.27 | 41.97 | 24.73 | KM Plot |
| TGCT | rs11326931 | chr17:39337781 | CT/C | 6.24E-7 | 134 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs113297557 | chr13:21844412 | T/C | 5.93E-7 | 132 | 46.3 | 36.7 | 14.42 | KM Plot |
| TGCT | rs113344010 | chr17:39366355 | A/AGG | 5.32E-7 | 130 | 13.17 | 46.03 | 42.18 | KM Plot |
| TGCT | rs113699397 | chr16:67542152 | C/CT | 0 | 127 | 48.35 | 25.55 | 0.57 | KM Plot |